Icahn School of Medicine at Mount Sinai, New York, NY, 2 Mount Sinai School of Medicine, New York, NY. RATIONALE: Inaccurate drug allergy designations in the adult population have been shown to increase broad-spectrum antibiotic use, medical costs, and morbidity. We hypothesized that the recording of drug allergies in the pediatric population is also imprecise and sought to assess the steps involved in recording drug allergies in a pediatric inpatient unit. METHODS: A prospective chart review of all patients admitted to a pediatric inpatient unit was conducted over a 4-week period. Data recorded for each patient included: demographics, drug allergy details, provider responsible for and location of allergy listing, infection type and antibiotic prescribed if applicable, and admitting/discharge diagnoses. RESULTS: A total of 145 patients were admitted to the unit. The inpatient physician and registered nurse reviewed the allergy section for only 60/145 (41.4%) patients. Total antibiotic allergies recorded were 9/145 (6.2%) patients, including 6/9 (66.7%) penicillin, 2/9 (22.2%) cephalosporin, and 1/9 (11.1%) sulfa allergies. Of the 9 patients with antibiotic allergies, reactions included ''rash'' (6/9, 66.7%), ''unknown'' (2/9, 22.2%), and ''hives'' (1/9, 11.1%) without additional details. Notably, 2/145 (1.4%) patients had incorrectly labeled drug allergies in the emergency department amended during the admission process. CONCLUSIONS: Drug allergies are inconsistently reviewed by physicians and nurses during the hospital admission process. As a consequence, medical errors are likely to increase when medications are prescribed. To overcome this flawed process, and promote judicious use of antibiotics, accurate allergy labeling and mandatory reconciliation prior to admission should be required. Future studies are needed to assess best approaches at antibiotic stewardship in the inpatient pediatric population. Maintenance of accurate drug allergy labels is critical to the safety and efficacy of future treatment choices. We assessed the accuracy and quality of drug allergy label transfer during the implementation of a simultaneous inpatient and outpatient electronic health record (EHR) transition. METHODS: A retrospective review of 511 random patients seen in an outpatient drug allergy clinic from March 5, 2014 to November 1, 2017 was performed to assess the accurate transfer of revised drug allergy labels between EHRs. RESULTS: A total of 114 label discrepancies were identified for 79/511 (15.4%) patients. Of these 114 labels, 40 (35%) suggested potentially severe reactions, and were either removed or downgraded in severity. Eight of the 28 patients with potentially severe reactions had an encounter in the new EHR. Seven patients who had been ''de-labeled'' in the 6 weeks prior to the EHR transition reverted back to their pre-testing drug allergy label following the EHR transition, including 9 penicillin, 4 sulfa, 1 fluoroquinolone and 1 cephalosporin labels. Re-labeling notably occurred with 19 medications post-transition compared with 14 pre-transition. CONCLUSIONS: Using a drug allergy clinic population with frequent label changes, we identified several deficits and discrepancies in drug allergy documentation that occurred during an EHR transition that potentially threatens patient care and safety. There was wide variability in documentation, differentiation of allergy versus intolerance and a significant risk of re-labeling patients as allergic, particularly for penicillin (45%). Given the significant threat to patient safety, urgent reform is required to standardize drug allergy documentation and prevent labeling errors.
